JP2025000750A5 - - Google Patents

Download PDF

Info

Publication number
JP2025000750A5
JP2025000750A5 JP2024165838A JP2024165838A JP2025000750A5 JP 2025000750 A5 JP2025000750 A5 JP 2025000750A5 JP 2024165838 A JP2024165838 A JP 2024165838A JP 2024165838 A JP2024165838 A JP 2024165838A JP 2025000750 A5 JP2025000750 A5 JP 2025000750A5
Authority
JP
Japan
Prior art keywords
aav vector
composition
subject
vector according
aav
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024165838A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025000750A (ja
JP7778879B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2020/017292 external-priority patent/WO2020163761A1/en
Application filed filed Critical
Publication of JP2025000750A publication Critical patent/JP2025000750A/ja
Publication of JP2025000750A5 publication Critical patent/JP2025000750A5/ja
Priority to JP2025199231A priority Critical patent/JP2026020285A/ja
Application granted granted Critical
Publication of JP7778879B2 publication Critical patent/JP7778879B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024165838A 2019-02-08 2024-09-25 ミオシン15プロモーター及びその使用 Active JP7778879B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025199231A JP2026020285A (ja) 2019-02-08 2025-11-19 ミオシン15プロモーター及びその使用

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201962802874P 2019-02-08 2019-02-08
US62/802,874 2019-02-08
US201962928311P 2019-10-30 2019-10-30
US62/928,311 2019-10-30
US202062965773P 2020-01-24 2020-01-24
US62/965,773 2020-01-24
PCT/US2020/017292 WO2020163761A1 (en) 2019-02-08 2020-02-07 Myosin 15 promoters and uses thereof
JP2021546388A JP7562544B2 (ja) 2019-02-08 2020-02-07 ミオシン15プロモーター及びその使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021546388A Division JP7562544B2 (ja) 2019-02-08 2020-02-07 ミオシン15プロモーター及びその使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025199231A Division JP2026020285A (ja) 2019-02-08 2025-11-19 ミオシン15プロモーター及びその使用

Publications (3)

Publication Number Publication Date
JP2025000750A JP2025000750A (ja) 2025-01-07
JP2025000750A5 true JP2025000750A5 (https=) 2025-03-31
JP7778879B2 JP7778879B2 (ja) 2025-12-02

Family

ID=71947522

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2021546388A Active JP7562544B2 (ja) 2019-02-08 2020-02-07 ミオシン15プロモーター及びその使用
JP2024165838A Active JP7778879B2 (ja) 2019-02-08 2024-09-25 ミオシン15プロモーター及びその使用
JP2025199231A Pending JP2026020285A (ja) 2019-02-08 2025-11-19 ミオシン15プロモーター及びその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021546388A Active JP7562544B2 (ja) 2019-02-08 2020-02-07 ミオシン15プロモーター及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025199231A Pending JP2026020285A (ja) 2019-02-08 2025-11-19 ミオシン15プロモーター及びその使用

Country Status (7)

Country Link
US (2) US12252520B2 (https=)
EP (1) EP3920974A4 (https=)
JP (3) JP7562544B2 (https=)
CN (3) CN119320772A (https=)
AU (1) AU2020218547A1 (https=)
CA (1) CA3129422A1 (https=)
WO (1) WO2020163761A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11660353B2 (en) 2018-04-27 2023-05-30 Decibel Therapeutics, Inc. Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
CN119410636A (zh) 2018-04-27 2025-02-11 分贝治疗公司 肌球蛋白15启动子及其用途
EP3921032A4 (en) 2019-02-08 2022-11-30 Decibel Therapeutics, Inc. COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS
CA3159549A1 (en) * 2019-10-30 2021-05-06 Decibel Therapeutics, Inc. Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
JP7807380B2 (ja) 2020-02-21 2026-01-27 アコーオス インコーポレイテッド ヒト対象において非加齢関連聴力障害を処置するための組成物および方法
CN112194717B (zh) * 2020-09-30 2021-12-14 东南大学 一种促进耳蜗毛细胞再生的肽段Tr及其应用
JP2025504263A (ja) 2021-12-23 2025-02-10 ユニバーシティ オブ ロチェスター 内耳への薬剤の送達のためのcsf輸送経路
JP2025503508A (ja) 2021-12-23 2025-02-04 ユニバーシティ オブ ロチェスター 内耳への薬剤の送達のための組成物及び方法
CN116836975A (zh) * 2022-03-25 2023-10-03 上海玮美基因科技有限责任公司 一种耳蜗和/或前庭细胞特异性启动子及其应用
WO2024250774A1 (zh) * 2023-06-07 2024-12-12 苏州星奥拓维生物技术有限公司 耳蜗外毛细胞特异性启动子及其应用
CN117486995A (zh) * 2023-11-03 2024-02-02 首都医科大学附属北京胸科医院 Kncn蛋白在结核诊断试剂中的应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9720465D0 (en) 1997-09-25 1997-11-26 Oxford Biomedica Ltd Dual-virus vectors
US6436392B1 (en) 1998-05-20 2002-08-20 University Of Iowa Research Foundation Adeno-associated virus vectors
EP1224313A1 (en) 1999-10-07 2002-07-24 University of Iowa Research Foundation Adeno-associated viruses and uses thereof
WO2001029243A1 (en) 1999-10-15 2001-04-26 Dalhousie University Method and vector for producing and transferring trans-spliced peptides
US20040072154A1 (en) * 2000-12-22 2004-04-15 Morris David W. Novel compositions and methods for cancer
JP2003088388A (ja) * 2001-09-14 2003-03-25 Herikkusu Kenkyusho:Kk 新規な全長cDNA
US20060024278A1 (en) * 2004-01-23 2006-02-02 The General Hospital Corporation Methods and products related to the production of inner ear hair cells
US20070161031A1 (en) * 2005-12-16 2007-07-12 The Board Of Trustees Of The Leland Stanford Junior University Functional arrays for high throughput characterization of gene expression regulatory elements
US8298818B2 (en) 2006-04-28 2012-10-30 University Of Florida Research Foundation, Inc. Self-complementary adeno-associated virus having a truncated CMV-chicken β-actin promoter
JP5575486B2 (ja) 2007-01-18 2014-08-20 ユニヴァーシティ オブ ミズーリー−コロンビア 筋鞘にnNOSを回復させる合成ミニ/ミクロジストロフィン遺伝子
FR2919305B1 (fr) 2007-07-26 2009-09-18 Genethon Ass Loi De 1901 Vecteurs viraux adeno-associes pour l'expression de la dysferline.
EP2732819B1 (en) 2008-02-07 2019-10-16 Massachusetts Eye & Ear Infirmary Compounds that enhance Atoh-1 expression
US8236557B2 (en) 2008-05-28 2012-08-07 University Of Missouri-Columbia Hybrid-AAV vectors to deliver large gene expression cassette
US8962314B2 (en) 2008-11-26 2015-02-24 The Regents Of The University Of California Lateral ventricle cell compositions and use for treating neural degenerative diseases
HRP20190144T1 (hr) 2010-04-23 2019-03-22 University Of Florida Research Foundation, Inc. Pripravci raav-gvanilat ciklaze i postupci za liječenje leberove urođene amauroze-1 (lca1)
WO2013075008A1 (en) 2011-11-16 2013-05-23 University Of Florida Research Foundation Inc. Aav dual vector systems for gene therapy
EP2802657B1 (en) * 2012-01-12 2018-05-02 Quark Pharmaceuticals, Inc. Combination therapy for treating hearing and balance disorders
US20150050354A1 (en) * 2012-04-02 2015-02-19 Moderna Therapeutics, Inc. Modified polynucleotides for the treatment of otic diseases and conditions
AU2013249202B2 (en) 2012-04-18 2018-08-09 The Children's Hospital Of Philadelphia Composition and methods for highly efficient gene transfer using AAV capsid variants
CA2884309A1 (en) * 2012-09-07 2014-03-13 Massachusetts Eye And Ear Infirmary Methods and compositions for regenerating hair cells and/or supporting cells from differentiated cochlear cells or differentiated utricular cells by modulation of notch and cmyc activity
CA2909733C (en) 2013-04-18 2023-10-17 Fondazione Telethon Effective delivery of large genes by dual aav vectors
KR102234672B1 (ko) 2013-05-21 2021-04-06 유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 캡시드-변형된 raav3 벡터 조성물, 및 인간 간암의 유전자 요법에서의 용도
US10751385B2 (en) 2015-02-20 2020-08-25 Institut Pasteur Prevention and/or treatment of hearing loss or impairment
RS63416B1 (sr) 2015-03-03 2022-08-31 Fond Telethon Sistem višestrukih vektora i njegove primene
SG11201804814YA (en) 2015-12-11 2018-07-30 Massachusetts Eye & Ear Infirmary Materials and methods for delivering nucleic acids to cochlear and vestibular cells
WO2017108931A1 (en) 2015-12-22 2017-06-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Improved hybrid dual recombinant aav vector systems for gene therapy
JP2019530737A (ja) 2016-08-23 2019-10-24 アコーオス インコーポレイテッド ヒト対象において非加齢性聴力障害を治療するための組成物および方法
WO2018145111A1 (en) 2017-02-06 2018-08-09 Children's Medical Center Corporation Materials and methods for delivering nucleic acids to cochlear and vestibular cells
AU2018261769B2 (en) 2017-05-05 2024-03-14 The Regents Of The University Of California Compositions and methods for expressing Otoferlin
DE102018103924A1 (de) 2018-02-21 2019-08-22 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Gentherapeutische Behandlung von Schwerhörigkeit
IL325122A (en) 2018-02-22 2026-02-01 Akouos Inc Compositions and methods for treating non-age-related hearing impairment in humans
CN119410636A (zh) * 2018-04-27 2025-02-11 分贝治疗公司 肌球蛋白15启动子及其用途
US11660353B2 (en) * 2018-04-27 2023-05-30 Decibel Therapeutics, Inc. Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
US12188041B2 (en) 2018-11-01 2025-01-07 University Of Florida Research Foundation, Incorporated Codon optimized otoferlin AAV dual vector gene therapy
CN118497276A (zh) 2018-11-07 2024-08-16 阿库斯股份有限公司 腺相关病毒载体用于在内耳中的毛细胞和支持细胞中校正基因缺陷/表达蛋白质的用途
WO2020148458A1 (en) 2019-01-18 2020-07-23 Institut Pasteur Aav-mediated gene therapy restoring the otoferlin gene
JP2022522995A (ja) 2019-01-18 2022-04-21 ボイジャー セラピューティクス インコーポレイテッド Aav粒子を生成するための方法及びシステム
EP3921032A4 (en) 2019-02-08 2022-11-30 Decibel Therapeutics, Inc. COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS
CA3159549A1 (en) 2019-10-30 2021-05-06 Decibel Therapeutics, Inc. Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
CN117295529A (zh) 2021-02-19 2023-12-26 分贝治疗公司 使用耳畸蛋白双载体系统治疗感觉神经性听力损失的方法
EP4665751A2 (en) 2023-02-17 2025-12-24 Decibel Therapeutics, Inc. Methods and compositions for administering otoferlin dual vector systems

Similar Documents

Publication Publication Date Title
JP2025000750A5 (https=)
JP2021521842A5 (https=)
JP2018536420A5 (https=)
US20220127621A1 (en) Fusion proteins and fusion ribonucleic acids for tracking and manipulating cellular rna
JP2021512649A5 (https=)
JP2017505626A5 (https=)
JP2025023947A5 (https=)
JP2022501060A5 (https=)
JP2017529395A5 (https=)
JP2025120285A5 (https=)
JP2021533801A5 (https=)
JP2021533803A (ja) Fasl免疫モジュレート遺伝子治療組成物および使用方法
JPWO2019153009A5 (https=)
JPWO2019210181A5 (https=)
JP2021527087A5 (https=)
JPWO2020163761A5 (https=)
CN115806984A (zh) 环状rna及载体和载体的应用
KR20230152768A (ko) 신규한 듀얼 헬퍼 플라스미드
JPWO2020069339A5 (https=)
JPWO2020084162A5 (https=)
JPWO2020245169A5 (https=)
CN113913463B (zh) 抑制sost基因表达的重组质粒及其骨靶向重组腺相关病毒与应用
JPWO2021076925A5 (https=)
US20250179129A1 (en) Zinc finger peptides, peptide arrays, and methods of use thereof
JP7853958B2 (ja) 組み換えaavの作製方法